What Tramedico does

Tramedico BV is a Dutch family-owned pharmaceutical distribution company founded in 1973 and headquartered in Weesp, the Netherlands (relocating to Naarden in August 2026). The company introduces and distributes prescription medicines and medical devices in the Netherlands on behalf of international pharmaceutical partners, operating as a specialty niche distributor rather than a manufacturer. Its portfolio spans ophthalmology, gastrointestinal and liver diseases (MDL), orthopedics, cardiology, urology, and ENT, with a deliberate focus on unpreserved formulations (eye drops, glaucoma medications, anti-allergics, antibiotics, corticosteroids) where preservatives can damage the ocular surface. Proprietary or own-brand assets include the AYZ dry-eye range (Start, Protect, Gel, Ointment, Eyelid Cream, Cleaning Wipes, and the newer Matrix3 muco-adhesive formulation) and the Adant hyaluronic acid injection franchise for osteoarthritis, licensed from Meiji Pharma Spain.

The company's commercial model combines pharmacy-channel distribution (prescription products and OTC dry-eye SKUs), a gated Specialist Portal (Specialistenportal.nl) that handles medical-professional engagement under pharmaceutical regulatory restrictions, the T-Pensant continuing medical education platform (15+ years in MDL, expanded to ophthalmology in 2022), and selective direct-to-patient ordering for products such as Adant and Gepan Instill. Headcount is reported in the 1-10 range, but the firm has been recognized with three consecutive FD Gazelle Awards (2022, 2023, 2024) for sustained annual revenue growth above 20%, and the company maintains long-standing distribution partnerships with Meiji Pharma Spain, Pharma Stulln, Preventis GmbH, Pohl-Boskamp, Galen Pharma, and ChiRhoClin. The team supports these partnerships through event participation (OVN Congress, Libelle Zomerweek), online CME training (MedNet partnership reaching 1,000+ GPs), and CSR activity (Eye Care Foundation sponsorship and Nepal study tours).

Name

Tramedico

Legal name

Tramedico BV

Website

https://tramedico.nl

Company type

Private

Founded year

1973

Operating status

Operating

Headcount range

1–10 employees

Short description

Tramedico BV is a Dutch family-owned specialty pharmaceutical distributor, founded 1973, that introduces and distributes prescription medicines and medical devices — with a focus on unpreserved ophthalmic formulations — in the Netherlands for international pharma partners serving eye-care, GI, and orthopedic specialists.

Ownership category

akta.pro rank

Headquarters

HQ city

Weesp

HQ country

Netherlands

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

1. Pharmaceutical Product Distribution: Tramedico introduces and distributes pharmaceutical medicines and medical devices in the Netherlands through partnerships with international pharmaceutical companies. Products include ophthalmic medications, gastrointestinal treatments, orthopedic solutions, and cardiology medications.
2. Medical Device Sales: Sale of medical devices including the AYZ product range for dry eye treatment (eye drops, eyelid cream, cleansing wipes), Adant hyaluronic acid injections for osteoarthritis, and diagnostic tests like the calprotectin home test.
3. Medical Education Services: Organization of continuing medical education events and training sessions (T-Pensant) for healthcare professionals, including accreditation and logistical support.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Tramedico is a Dutch family business (founded 1973) that introduces and distributes pharmaceutical medicines and medical devices from international partners into the Netherlands. The company specializes in unpreserved ophthalmology products (notably the AYZ dry eye range), gastrointestinal and liver disease (MDL) treatments, orthopedic intra-articular injections, and selected cardiology, urology and ENT products. Beyond product distribution, Tramedico organizes continuing medical education programs (T-Pensant) and maintains a Specialist Portal for healthcare professionals.

Product overview

Tramedico is a Dutch family business (founded 1973) that introduces and distributes pharmaceutical medicines and medical devices in the Netherlands. The company specializes in Ophthalmology, Gastrointestinal/Liver diseases, and Orthopedics, with additional products in Cardiology and Urology. The product portfolio includes the AYZ brand range (unpreserved eye drops, ointments, lid care products for dry eyes and various eye conditions), prescription ophthalmic medications (glaucoma treatments, anti-inflammatory, anti-allergic, antibiotics), gastrointestinal products (laxatives, pancreatic enzymes, calprotectin home test), orthopedic treatments (hyaluronic acid injections for osteoarthritis), cardiovascular products (nitroglycerin spray), urology (bladder instillation), and ENT products (ear drops). The AYZ assortment provides multiple unpreserved options for dry eye disease, while the prescription portfolio focuses on unpreserved medications to minimize ocular surface damage.

Differentiator

Problem solved

Functional benefit

Brands

• AYZ: AYZ is a product brand for unpreserved eye care products including eye drops, eyelid cream, and cleaning wipes for dry eyes treatment.
• Adant

Products and services

• AYZ Matrix3 Advanced preservative-free eye drop for dry eye symptoms combining hyaluronic acid, trehalose and arabinogalactan in a 3-in-1 muco-adhesive formulation for longer-lasting contact with the ocular surface; for patients with dry eyes including contact lens wearers.
• AYZ Gel eye drops Higher-viscosity eye drops containing 0.3% sodium hyaluronate for dry eye patients who need to apply drops multiple times daily.
• AYZ Protect eye drops Eye drops containing 0.15% sodium hyaluronate and 2% dexpanthenol for extra eye protection and healing of the eye surface.
• AYZ Start eye drops Basic preservative-free eye drops containing 0.15% sodium hyaluronate for treating dry eyes, suitable for daily use and contact lens wearers.
• AYZ Eye ointment Isotonic eye ointment containing 0.4% sodium hyaluronate for overnight moistening and protection of the eye surface.
• AYZ Eyelid cream Eyelid cream containing 5% panthenol, vitamin E, bisabolol and hyaluronic acid for preventive care of dry and irritated eyelid skin.
• AYZ Cleaning wipes Cleansing wipes made from natural cotton with aloe vera, tea tree extract and sodium hyaluronate for eyelid hygiene.
• Hylan Preservative-free artificial tear fluid for protection against dehydration of the eyes, used in Sjögren's syndrome and situations where eyes cannot close.
• Ketotifen (MD) Multi-dose preservative-free anti-allergic eye drops containing ketotifen 0.25 mg/ml for treatment of seasonal allergic conjunctivitis.
• Ketotifen (single-dose) Single-dose unit preservative-free anti-allergic eye drops containing ketotifen for hay fever treatment.
• OCUsalin Preservative-free 5% hypertonic saline solution for treatment of corneal edema after eye surgery or diagnostic procedures.
• Bimatoprost Preservative-free eye drop in multidose bottle for reduction of increased intraocular pressure in chronic open-angle glaucoma and ocular hypertension.
• Brimonidine Preservative-free eye drops for lowering eye pressure in treatment of open-angle glaucoma or ocular hypertension.
• Dorzolamide + Timolol Preservative-free eye drops combining carbonic anhydrase inhibitor (dorzolamide) and beta blocker (timolol) for glaucoma treatment.
• Ofloxacine eye drops Topical antibiotic eye drops for treatment of external eye infections including bacterial conjunctivitis and keratitis.
• Dexamethason Tramedico Preservative-free corticosteroid eye drops for treating inflamed eyes and reducing post-cataract surgery inflammation.
• Macrogol and electrolytes Natural InterGal Prescription laxative containing macrogol 3350 and electrolytes for treatment of chronic constipation in adults and children from 12 years.
• Macrogol and electrolytes Natural InterGal Junior Pediatric laxative powder for oral solution for treatment of chronic constipation and fecal impaction in children aged 2 to 11 years.
• Colex Rectal enema solution for emptying the colon and rectum for occasional constipation, diagnostic procedures, and childbirth preparation.
• Pantriozyme Capsules containing pancreatin (lipase, protease, and amylase) for treatment of exocrine pancreatic insufficiency in chronic pancreatitis and cystic fibrosis.
• Preventis SmarTest Calprotectin Home Home test kit using QuantOn Technology to detect calprotectin in stool, helping distinguish IBD from irritable bowel syndrome via smartphone app evaluation.
• Adant Intra-articular hyaluronic acid injections for treatment of osteoarthritis pain and reduced mobility, administered weekly for 3-5 consecutive weeks.
• Adant One Single intra-articular hyaluronic acid injection for osteoarthritis treatment.
• Nitrolingual Pump Spray Sublingual nitroglycerin spray for treatment and prevention of angina pectoris.
• Gepan Instill Sterile solution with chondroitin sulphate for temporary replenishment of the protective bladder layer in interstitial cystitis.
• Otiflox Ofloxacin ear drops for treatment of middle ear infections including chronic purulent otitis media and acute otitis media with tympanostomy tubes.
• T-Pensant Continuing Medical Education Program Accredited continuing medical education platform organized by Tramedico for healthcare professionals, including T-Pensant regional meetings for MDL specialists (15+ years) and ophthalmic specialists (since 2022), with case discussions, state-of-the-art lectures and logistical support.

Quantifiable outcome

• 1000+ general practitioners trained in Ocular Surface Disease online
• +2 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Meiji Pharma Spain, S.A.coreTechnology or IntegrationPartnership since beginning of this century. Meiji has 25+ years expertise in hyaluronic acid-based products for joint and eye treatments. Markets Adant hyaluronic acid injection for osteoarthritis in Netherlands. Approved in 45+ countries with 13+ million treatments administered globally.
• Pharma StullncoreTechnology or IntegrationLongstanding partnership with German company in Stulln. Many products in Tramedico's unpreserved eye medication range originate from Pharma Stulln. Nearly annual introduction of new innovative products to Dutch market.
• Preventis GmbHcoreTechnology or IntegrationGerman company (founded 2003, Bensheim) specializing in point-of-care diagnostics and telemedicine solutions. Introduced SmarTest series and QuantOn Technology for rapid test evaluation via smartphone app in Netherlands.
• Pohl-BoskampcoreTechnology or IntegrationGerman family business (4th generation) based in Hohenlockstedt. Markets Gepan Instill for interstitial cystitis and Nitrolingual Pump Spray for angina pectoris. Exports to 50 countries. Collaboration revived in 2018 with Tramedico handling marketing and sales.
• Rx-AllianceminorStrategic or Co-development PartnerPartnership of independent European pharmaceutical companies offering platform in regulatory, legal and medical fields to optimize product introduction in local markets. Tramedico is a member seeking European partners for innovative products.
• Eye Care FoundationcoreOthersTramedico sponsors Eye Care Foundation for multiple years. Supports eye care in Nepal through donations. Team members visited Himalaya Eye Hospital in Pokhara to witness ECF impact. Sponsor of Dam tot Damloop 2025 raising EUR 43,018 for jeep purchase.
• Nawa Vision CareminorOthers2025 donation recipient. Foundation bringing eye care to communities in Zambia where care is unavailable. Works with Lusaka Eye Hospital to conduct eye examinations and cataract surgeries. Co-founded by former refugees from Rwanda and Congo.
• MedNetminorStrategic or Co-development PartnerPartnership for online continuing medical education. Jointly organized Ocular Surface Disease (OSD) online training reaching 1000+ general practitioners on dry eyes and blefaritis.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Laboratoires Théa: French-headquartered, family-owned European ophthalmology specialist with a strong focus on preservative-free formulations and a broad dry-eye, glaucoma, and allergy portfolio. Closely comparable to Tramedico in mission, geographic focus, and product philosophy around unpreserved eye medications.
• Will-Pharma: Dutch specialty pharmaceutical distribution and marketing company of similar size and orientation to Tramedico, also active in introducing niche and specialty products into the Benelux market. A natural local competitor for international partner mandates.
• Ursapharm: German specialty pharma company with a flagship range of preservative-free eye drops (Hylo) and a portfolio that overlaps directly with Tramedico's AYZ and PF ophthalmic lines. Highly relevant as a like-for-like competitor in the preservative-free European ophthalmology niche.
• TRB Chemedica: German specialty pharma firm combining preservative-free ophthalmology (Vismed, Hylo-like lines) with hyaluronic-acid intra-articular injections for osteoarthritis. Closely mirrors Tramedico's ophthalmology + orthopedics (Adant) combination, making it one of the most direct functional analogs.

Broad incumbents

• AbbVie (Allergan Aesthetics / Eye Care): Owns the former Allergan eye-care franchise (including dry eye and glaucoma treatments such as Restasis and Lumigan), making it a major broad incumbent competing in the same ophthalmology categories as Tramedico.
• Alcon: Global leader in eye care with extensive surgical and ophthalmic pharmaceutical portfolios, active in the same ophthalmologist and pharmacy channels as Tramedico in the Dutch market.
• Bausch + Lomb: Major global eye-care company covering ophthalmic pharmaceuticals, lens care, and surgical products. Represents the broader incumbent competitive set in the same HCP and pharmacy channels Tramedico serves in the Netherlands.
• Santen Pharmaceutical: Japanese-headquartered global ophthalmology specialist with a strong European subsidiary and broad portfolio across dry eye, glaucoma, and surgical. Larger incumbent that competes with Tramedico's ophthalmology franchise in the Netherlands.

Emerging players

• Horus Pharma: French independent ophthalmology company focused on preservative-free and specialty eye-care formulations. Smaller, niche European player operating in adjacent product categories and a useful emerging-comparable for Tramedico's AYZ-style portfolio.

Others

• Croma-Pharma: Austrian specialty company active in ophthalmology (e.g., preservative-free eye drops) and hyaluronic-acid-based aesthetics/orthopedics. Adjacent comparator in Tramedico's two strongest therapeutic pillars (eye care and HA-based orthopedics).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Tramedico-BV-119433266130314

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tramedico